An analyst from Jefferies initiated coverage of IO Biotech (NASDAQ: IOBT) at 'buy' with a price target of $12.00 from a prior price target of %currency%%price%. Prior to this rating, IO...
Investing.com - IO Biotech (NASDAQ: IOBT) reported first quarter EPS of $-0.59, $0.10 better than the analyst estimate of $-0.69. Revenue for the quarter came in at $0.00 versus the...
Investing.com - IO Biotech (NASDAQ: IOBT) reported fourth quarter EPS of $-0.69, $0.11 worse than the analyst estimate of $-0.58. Revenue for the quarter came in at $0.00 versus the...
Investing.com - IO Biotech reported on Wednesday third quarter {{erl-1179157||earnings that beat analysts' forecasts and revenue that was inline with expectations. IO Biotech announced...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Technology, Consumer Services and Consumer Goods sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Consumer Services, Technology and Financials sectors propelled shares lower. At the close in NYSE, the Dow...
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Technology, Financials and Consumer Goods sectors propelled shares lower. At the close in NYSE, the Dow...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
